Results 111 to 120 of about 31,914 (284)

Symptomatic Deep Venous Thrombosis of the Upper Extremity Following Transvenous Lead Extraction, Data From EXTRACT Registry

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background Venous thrombosis occurring after TLE procedures is a fairly common but poorly described complication and requires further investigation into its causes. Aim The aim of this study was to identify independent predictors of UEDVT occurrence after TLE procedures.
Michal Joniec   +9 more
wiley   +1 more source

Twice- or once-daily dosing of novel oral anticoagulants for stroke prevention: a fixed-effects meta-analysis with predefined heterogeneity quality criteria. [PDF]

open access: yesPLoS ONE, 2014
A number of novel oral anticoagulants (direct thrombin inhibitors or factor Xa inhibitors) are in clinical use for various indications. The dosing regimens differ between twice-daily and once-daily dosing for the prevention of stroke in patients with ...
Andreas Clemens   +3 more
doaj   +1 more source

Threats to safe transitions from hospital to home: a consensus study in North West London primary care. [PDF]

open access: yes, 2019
BACKGROUND: Transitions between healthcare settings are vulnerable points for patients. AIM: To identify key threats to safe patient transitions from hospital to primary care settings.
Ashrafian, H.   +5 more
core   +2 more sources

Averaged Impedance Drop Estimates Conduction Gap During Pulmonary Vein Isolation in Atrial Fibrillation

open access: yesJournal of Cardiovascular Electrophysiology, EarlyView.
ABSTRACT Background EnSite X provides a module to filter oscillated generator impedance signals due to cardiac beating/respiration (averaged impedance drop, AID). TactiFlex ablation catheter Sensor Enabled (TFSE) is the latest product to incorporate a contact‐force sensor with a flexible tip but without lesion‐estimating parameters.
Masahide Harada   +6 more
wiley   +1 more source

Left Atrial Appendage Thrombus in Patients With Hypertrophic Cardiomyopathy and Atrial Fibrillation: Prevalence and Risk Factors

open access: yesJournal of the American Heart Association: Cardiovascular and Cerebrovascular Disease
Background Atrial fibrillation (AF) is common in hypertrophic cardiomyopathy (HCM) and increases stroke risk, primarily due to thromboembolism from the left atrial appendage (LAA). Oral anticoagulation (OAC) is recommended, but data on LAA thrombus (LAAT)
Leon Dinshaw   +14 more
doaj   +1 more source

Direct oral anticoagulants versus warfarin: is new always better than the old? [PDF]

open access: yes, 2018
About 1.4 British million people are at risk of strokes due to non-valvular atrial fibrillation (AF) necessitating long-term anticoagulation. The vitamin K antagonist, warfarin, has a long half-life and narrow therapeutic range necessitating regular ...
Burn, John, Pirmohamed, Munir
core   +1 more source

Role of comorbidities and medication on immunotherapy efficacy in cSCC: A DeCOG multicentre analysis

open access: yesJournal of the European Academy of Dermatology and Venereology, EarlyView.
Immunosuppressive disease was associated with reduced overall survival, while anticoagulant use was linked to prolonged progression‐free survival in advanced cutaneous squamous cell carcinoma treated with immune checkpoint inhibitors. Host‐related factors may modulate immunotherapy efficacy and warrant prospective validation.
Glenn Geidel   +27 more
wiley   +1 more source

Newer non-vitamin K-antagonist direct oral anticoagulants in acute coronary syndromes

open access: yesItalian Journal of Medicine, 2013
standard dual antiplatelet therapy (DAPT) of aspirin and clopidogrel is associated with a substantial absolute incidence of adverse events, including death, myocardial infarction and stroke after an acute coronary syndrome (ACs).
Andrea Rubboli
doaj   +1 more source

Non–Vitamin K Antagonist Oral Anticoagulants for Stroke Prevention in Asian Patients With Nonvalvular Atrial Fibrillation

open access: yesStroke, 2015
Background and Purpose— The use of vitamin K antagonists (VKAs), the cornerstone treatment for stroke prevention in patients with atrial fibrillation, is limited by the perceived risk of serious bleeding in Asia.
Kang-Ling Wang   +3 more
semanticscholar   +1 more source

Jugular Journeys: A Novel Approach for AVEIR Leadless Pacemaker Implantation

open access: yesPacing and Clinical Electrophysiology, EarlyView.
ABSTRACT Background The jugular approach for Micra leadless pacemaker (LP) implantation offers potential advantages over the femoral route, however data on safety and feasibility for the relatively larger AVEIR LP implantation through the jugular vein is limited.
Shmaila. Saleem‐Talib   +6 more
wiley   +1 more source

Home - About - Disclaimer - Privacy